Connection

Elizabeth Garrett-Mayer to Vidarabine

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Vidarabine.
Elizabeth Garrett-Mayer
Connection Strength
0.016
Vidarabine
  1. Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia. Clin Cancer Res. 2005 Dec 01; 11(23):8413-7.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.